Medical News

RSS

XRCC2 gene mutations cause increased breast cancer risk

Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not have mutations in the currently known breast cancer susceptibility genes.

30 Mar 2012

BG Medical forms new digital services marketing division

BG Medical Technologies, Inc., a leader in medical marijuana professional services, announces the formation of a new digital services marketing division to create best-in-class asset management for cannabis related Internet properties.

30 Mar 2012

Perspectives on the court and the health law: Is this judicial activism?; Decision could define Roberts; Health economics 101

The ideological nature of the health care case was obvious on the last day of oral argument. By the time the proceedings were over, much of what the conservative justices said in court seemed like part of a politically driven exercise - especially because the issues addressed on Wednesday were not largely constitutional in nature.

30 Mar 2012

Consumer should be centre of care when offering alternative medicine brands

NPS is reminding pharmacists to place patient care first and avoid multiple switching of medicine brands for patients who may be at higher risk of confusion from switching, as price disclosure arrangements come into effect this weekend.

29 Mar 2012

Sitting more than four hours a day could raise risk of dying early: Study

According to Australian researchers spending less time sitting could boost longevity. Their study of more than 220,000 NSW residents found the longer you spend sitting down the greater your risk of dying early, even if you otherwise do regular exercise.

29 Mar 2012

Dementia numbers to triple by 2050: Australian Report

In a discussion paper given to the State Government, Alzheimer's Australia NSW estimates the number of Australians diagnosed with dementia will rise from 280,000 to around 943,000 by 2050. Of these, 303,500 people will be from NSW.

29 Mar 2012

Two drinks a day after first heart attack may reduce death risk among men: Study

The study, carried out by researchers at Brigham and Women's Hospital in Boston, found that men who consumed two alcoholic drinks per day after their first heart attack were at lower risk of dying than non-drinking men. The type of drink did not have an effect on the results, but heavy drinkers had a risk of death that was similar to that of non-drinkers.

29 Mar 2012

Music helps relieve anxiety during surgery: Study

According to research playing music to patients undergoing surgery reduces their anxiety and could improve healing. Easy listening music and chart classics can lessen fear among patients who stay awake during surgery but require a local anesthetic say researchers.

29 Mar 2012

Green Coffee beans - the new weight loss formula

Green coffee beans could be the newest weight-loss fad as a new study finds that the bean extract may help people lose weight. When roasted at 475 degrees, coffee beans are sometimes described as rich and full-bodied. Before that they are termed green.

29 Mar 2012

Federal Court refuses to reconsider bone marrow donor payments

According to a federal appeals court it would not reconsider a ruling that allows bone marrow donors to be paid for their donations like blood donors.

29 Mar 2012

Cancer death rates declining but obesity still needs to be tackled

According to a new report from four major national cancer tracking groups there has been a steady decline in cancer death rates for men, women and children from 2004 to 2008. The declines in death and new cases of cancer reflect progress against the disease in terms of prevention, diagnosis and treatment, but experts say rising obesity may present a new challenge in the fight against cancer.

29 Mar 2012

Latest updates in clinical practice decision-making in cancer care presented at NCCN 17th conference

The National Comprehensive Cancer Network (NCCN) held the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care, March 14 - 18 at The Westin Diplomat in Hollywood, Florida. The latest updates in clinical practice decision-making in cancer care were presented, including, but not limited to, the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening and updates to the NCCN Guidelines for Melanoma and Non-Hodgkin's Lymphomas.

29 Mar 2012

Lilly's ixekizumab Phase II trial on plaque psoriasis meets primary endpoint

New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.

29 Mar 2012

First Edition: March 29, 2012

Today's health policy headlines include reports detailing Wednesday's Supreme Court oral arguments on severability as well as the Medicaid expansion. News coverage also sums up the week's high court activity and looks forward to what might happen next.

29 Mar 2012

BMI not linked with either surgical complications or esophageal cancer patient survival

Researchers at Moffitt Cancer Center in Tampa, Fla., have found - contrary to previous studies linking inferior outcomes in patients with gastrointestinal malignancies to higher body mass index (BMI) - that in their study of BMI and negative outcomes, there was no such link. They concluded that BMI was not associated with either surgical complications or esophageal cancer patient survival.

29 Mar 2012

Enrolment complete in Veloxis LCP-Tacro Phase III study in de novo kidney transplant patients

Veloxis Pharmaceuticals A/S today announced that enrolment has been completed in its pivotal LCP-Tacro Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is designed to demonstrate non-inferiority versus the gold standard therapy Prograf and has randomized over 540 patients at approximately 90 clinical sites around the world.

29 Mar 2012

Papillary renal cell carcinoma patients face low tumour re-occurrence and cancer-related death rates

Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumour recurrence and cancer-related death after surgery. Those are the key findings of a multi-centre study of nearly 600 patients published in the April issue of the urology journal BJUI.

29 Mar 2012

MO BIO introduces PowerMicrobiome RNA Isolation Kit

MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of the PowerMicrobiome RNA Isolation Kit, the first kit available that is optimized for stool and gut material and provides high quality RNA for use in characterizing the human microbiome.

29 Mar 2012

ProImmune introduces Special Assay Service

ProImmune Ltd., a leader in services for understanding immune responses, has launched a new Special Assay Service, providing unique, bespoke immunological assays, based on ProImmune's broad ranging proprietary platform technologies, to meet customers' assay needs.

29 Mar 2012

Rare total shoulder replacement performed using rotator cuff sparing approach

On Tuesday, March 6, 2012, Ryan Simovitch, M.D., Board Certified and fellowship trained orthopedic surgeon, performed one of the first successful total shoulder replacements with a rotator cuff sparing technique in South Florida. Jupiter Medical Center remains on the leading edge of orthopedics, offering orthopedic surgeons, state-of-the-art facilities, and comprehensive rehabilitation services to help patients return to an active and healthy lifestyle.

29 Mar 2012